Sabal Trust Co Has Lowered Its Boeing Co (BA) Position; Shorts at Stemline Therapeutics (STML) Lowered By 7.4%

March 23, 2018 - By Nellie Frank

Stemline Therapeutics Inc (NASDAQ:STML) had a decrease of 7.4% in short interest. STML’s SI was 1.58M shares in March as released by FINRA. Its down 7.4% from 1.71 million shares previously. With 499,000 avg volume, 3 days are for Stemline Therapeutics Inc (NASDAQ:STML)’s short sellers to cover STML’s short positions. The SI to Stemline Therapeutics Inc’s float is 8.09%. The stock increased 2.53% or $0.35 during the last trading session, reaching $14.2. About 572,683 shares traded or 70.21% up from the average. Stemline Therapeutics, Inc. (NASDAQ:STML) has risen 52.65% since March 23, 2017 and is uptrending. It has outperformed by 35.95% the S&P500.

Sabal Trust Co decreased Boeing Co (BA) stake by 24.35% reported in 2017Q3 SEC filing. Sabal Trust Co sold 36,785 shares as Boeing Co (BA)’s stock rose 4.66%. The Sabal Trust Co holds 114,292 shares with $29.05M value, down from 151,077 last quarter. Boeing Co now has $187.68 billion valuation. The stock decreased 5.19% or $17.49 during the last trading session, reaching $319.61. About 7.28M shares traded or 21.60% up from the average. The Boeing Company (NYSE:BA) has risen 41.13% since March 23, 2017 and is uptrending. It has outperformed by 24.43% the S&P500.

Among 25 analysts covering Boeing (NYSE:BA), 17 have Buy rating, 1 Sell and 7 Hold. Therefore 68% are positive. Boeing had 104 analyst reports since August 26, 2015 according to SRatingsIntel. JP Morgan downgraded the shares of BA in report on Friday, February 12 to “Neutral” rating. Morgan Stanley maintained The Boeing Company (NYSE:BA) on Tuesday, October 24 with “Equal-Weight” rating. Credit Suisse maintained The Boeing Company (NYSE:BA) on Tuesday, October 24 with “Buy” rating. The rating was initiated by Morgan Stanley with “Overweight” on Thursday, June 23. The stock of The Boeing Company (NYSE:BA) has “Neutral” rating given on Thursday, February 18 by Buckingham Research. The company was maintained on Wednesday, January 3 by Seaport Global. The rating was maintained by Cowen & Co on Monday, July 24 with “Buy”. The stock of The Boeing Company (NYSE:BA) has “Sector Perform” rating given on Thursday, April 28 by RBC Capital Markets. The rating was upgraded by Edward Jones to “Buy” on Tuesday, February 13. Cowen & Co maintained The Boeing Company (NYSE:BA) rating on Friday, December 1. Cowen & Co has “Buy” rating and $320.0 target.

Sabal Trust Co increased Cisco Sys Inc (NASDAQ:CSCO) stake by 36,119 shares to 757,423 valued at $25.47 million in 2017Q3. It also upped Procter And Gamble Co (NYSE:PG) stake by 10,555 shares and now owns 376,760 shares. Paychex Inc (NASDAQ:PAYX) was raised too.

Analysts await The Boeing Company (NYSE:BA) to report earnings on April, 25. They expect $2.66 earnings per share, up 32.34% or $0.65 from last year’s $2.01 per share. BA’s profit will be $1.56B for 30.04 P/E if the $2.66 EPS becomes a reality. After $4.80 actual earnings per share reported by The Boeing Company for the previous quarter, Wall Street now forecasts -44.58% negative EPS growth.

Since February 8, 2018, it had 0 insider purchases, and 1 sale for $12.17 million activity. Smith Gregory D sold $12.17 million worth of stock or 36,079 shares.

Investors sentiment decreased to 0.79 in 2017 Q3. Its down 0.02, from 0.81 in 2017Q2. It worsened, as 50 investors sold BA shares while 609 reduced holdings. 165 funds opened positions while 367 raised stakes. 411.79 million shares or 1.95% less from 419.99 million shares in 2017Q2 were reported. Hancock Holdg holds 0.71% of its portfolio in The Boeing Company (NYSE:BA) for 66,141 shares. Lord Abbett Ltd Limited Liability Company holds 0.13% or 170,568 shares. Patten Group Inc holds 0.61% of its portfolio in The Boeing Company (NYSE:BA) for 66,067 shares. Amica Pension Fund Board Of Trustees stated it has 21,377 shares. 848 are held by Alesco Advsrs Ltd Liability Company. West Coast Financial reported 26,166 shares. Tru Of Toledo Na Oh invested in 0.32% or 4,983 shares. Cap Advsrs Ltd Liability Corporation owns 498 shares. Kingfisher Capital Ltd Liability Corporation, a North Carolina-based fund reported 1,012 shares. 4,999 are held by Sonata Cap Grp Inc Incorporated. Canada Pension Plan Investment Board reported 0.33% stake. Cornerstone Inv Prtn Limited Liability Corp owns 0.02% invested in The Boeing Company (NYSE:BA) for 4,330 shares. Bnp Paribas Arbitrage holds 0.74% or 1.19 million shares in its portfolio. Neumann Capital Mngmt Ltd holds 0.14% in The Boeing Company (NYSE:BA) or 900 shares. Guild Inc owns 1,960 shares.

Since December 15, 2017, it had 0 insider buys, and 14 insider sales for $2.80 million activity. The insider Bergstein Ivan sold $421,170. Hoberman Kenneth sold $29,005 worth of stock. Gionco David also sold $156,604 worth of Stemline Therapeutics, Inc. (NASDAQ:STML) on Monday, February 26.

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercialization of proprietary oncology therapeutics in the United States. The company has market cap of $395.38 million. The firm develops SL-401, a targeted therapy directed to the interleukin-3 receptor , which is in Phase II clinical trial for patients with blastic plasmacytoid dendritic cell neoplasm, myeloproliferative neoplasms, and acute myeloid leukemia; and in Phase I clinical trial in combination with other agents for patients with relapsed/refractory multiple myeloma. It currently has negative earnings. It also develops SL-801, a novel oral small molecule reversible inhibitor of a tumor-promoting nuclear transport protein, which is in Phase I clinical trial for the treatment of solid and hematologic cancers; and SL-701, an immunotherapy that is in Phase II clinical trial to attack brain cancer.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: